Music Therapy in Obsessive Compulsive Disorder

Depression Clinical Trial

Official title:

A Randomized Clinical Trial of Music Therapy as an Adjunct to Standard Treatment for Obsessive Compulsive Disorder and Co-morbid Anxiety and Depression in Iran

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02314195
• Other study ID #: 2172719
• Status: Completed
• Phase: N/A
• First received: November 27, 2014
• Last updated: December 10, 2014
• Start date: April 2014
• Est. completion date: August 2014

Study information

• Verified date: December 2014
• Source: Islamic Azad University, Marvdasht
• Contact: n/a
• Is FDA regulated: No
• Health authority: Iran: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

Previous studies have highlighted the potential therapeutic benefits of receptive individual music therapy as an adjunct to standard care, in a variety of psychiatric ailments including mood and anxiety disorders. However, the role of music in the treatment of obsessive compulsive disorder have not been investigated to date. The present study therefore aimed to investigate the efficacy of music therapy as an adjunct to standard treatment, on obsessions in patients with treatment-naïve OCD. Moreover, given the fact that a significant proportion of patients with OCD have other comorbid mood or anxiety disorders, the question of whether therapeutic benefits of music could be expanded to also affect concurrent depressive and anxiety symptoms was explored.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: August 2014
• Est. primary completion date: June 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• were at least 18 years or older;

• had axis I diagnosis of OCD according to the criteria delineated by the diagnostic and statistical manual of mental disorders - fourth edition diagnosed by an experienced psychiatrist

• had not received treatment previously for the disorder

• agreed to partake in the study

Exclusion Criteria:

• refused to partake in the study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Anxiety
• Compulsive Behavior
• Depression
• Disease
• Obsessive-Compulsive Disorder

Intervention

Drug:
• Selective serotonin re-uptake inhibitor
A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.

Behavioral:
• Cognitive Behavioral Therapy
Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.

Other:
• Music therapy
12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.

Locations

Country	Name	City	State
Iran, Islamic Republic of	Shariati Hospital	Esfahan

Sponsors (1)

Lead Sponsor	Collaborator
Islamic Azad University, Marvdasht

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Obsession (Maudsley Obsessive-Compulsive Inventory)	Post-intervention scores on Maudsley Obsessive-Compulsive Inventory	1 month	No
Secondary	Obsession subtype (Maudsley Obsessive-Compulsive Inventory sub-types)	Post-intervention scores on Maudsley Obsessive-Compulsive Inventory sub-types	1 month	No
Secondary	Anxiety symptoms (Beck Anxiety Inventory)	Post-intervention scores on Beck Anxiety Inventory	1 month	No
Secondary	Depressive symptoms (Beck Depression Inventory - Short Form)	Post-intervention scores on Beck Depression Inventory - Short Form	1 month	No